Compound Summary
药名: | 18beta-glycyrrhetinic acid |
别名: | AJ-72559; Rhetinic Acid; C02283; GLYCYRRHETINIC ACID; 18-beta-Glycyrrhetinic acid; 1449-05-4; Glycyrrhetic acid; Hidermart; CHEMBL230006; SMR000058239; SR-01000721867-5; NCGC00142473-03; 18beta-Glycyrrhetinic acid, purum, >=97.0% (T); UNII-P540XA09DR; Enoxolone (Glycyrrhetin); 107420-91-7; Enoxolone, Glycyrrhetinic acid; CCRIS 3962; LMPR0106150014; 18beta-Glycyrrhetic acid; 4-10-00-03775 (Beilstein Handbook Reference); BB_NC-0599; HMS2233P23; LS-7417; (3?)-3-Hydroxy-11-oxoolean-12-en-30-oic acid; Opera_ID_1048; D0U8IF; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; NSC-35350; Olean-12-en-30-oic acid, 3beta-hydroxy-11-oxo- (8CI); AC-1925; Glycyrrhetinic acid; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-2,4a,6a,6b,9,9,12a-heptamethyl-10-oxidanyl-13-oxidanylidene-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; HY-N0180; Arthrodont; Hidermart (TN); DTXSID9020669; SR-01000721867-3; MLS002207101; Enoxolona; Glycyrrhetinic acid (JAN); A-Hydroxy-11-oxoolean-12-en-30-olic acid; SR-01000721867-6; Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3beta,20beta)-; (3beta)-3-hydroxy-11-oxoolean-12-en-30-oic acid; subglycyrrhelinic acid; SCHEMBL18540; 471-53-4; Olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-; BG01168029; FT-0082445; BX-1; Glycyrrhetin; D00156; NCGC00017244-03; 202522-39-2; 18-beta-Glycyrrhetic acid; SR-01000721867-4; Enoxolonum [INN-Latin]; SBB006496; GM-1658; Q-201057; NSC-35347; NSC 35347; (5S,8S,15S,18S,1R,2R,10R,14R,20R)-18-hydroxy-1,2,5,8,15,19,19-heptamethyl-13-o xopentacyclo[12.8.0.0<2,11>.0<5,10>.0<15,20>]docos-11-ene-8-carboxylic acid; alpha-Glycyrrhetinic acid; Tox21_112726; 130100-EP2295411A1; ZINC19203131; Biosone; D08LGJ; Bio-0549; Enoxolone; 18beta-Glycyrrhetinic acid; 3?-Hydroxy-11-oxo-18?,20?-olean-12-en-29-oic acid; Enoxolone (Glycyrrhetinic acid); 50510_FLUKA; BDBM50233538; Uralenic acid; NCGC00017244-04; P540XA09DR; 18beta-glycyrrhetic acid; C30H46O4; Jintan; Olean-12-en-30-oic acid, 3beta-hydroxy-11-oxo-; CAS-471-53-4; Tox21_200799; SR-01000721867; Enoxolone (INN); MLS001146949; MLS000028748; [(125)I] RB129; G10105_ALDRICH; (3beta,20beta)-3-Hydroxy-11-oxo-olean-12-en-29-oic acid; s2296; CCG-208506; 8055-71-8; EINECS 207-444-6; (2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid; Enoxolona [INN-Spanish]; GlycyrrhetinicAcid; 18b-Glycyrrhetic acid; AC1L1UIT; 130100-EP2269977A2; KS-1262; Glycyrrhetinate; Glycyrrhetinic acid [JAN]; (3alpha,5xi,8alpha,9xi,17alpha,18xi)-3-hydroxy-11-oxoolean-12-en-29-oic acid; BC201656; Enoloxone; Enoxolone [INN:BAN:DCF]; 18 beta-glycyrrhetinic acid; 3beta-Hydroxy-11-oxo-18beta,20beta-olean-12-en-29-oic acid; enoxolone; DSSTox_RID_75722; 18 beta-Glycyrrhetintic Acid; DSSTox_CID_669; 3-Glycyrrhetinic acid; 3beta-hydroxy-11-oxoolean-12-en-29-oic acid; NCGC00181115-01; Enoxolone; STX-352; AKOS016036757; 15301-63-0; G0149; MFCD00003706; ST24038257; Enoxolone, European Pharmacopoeia (EP) Reference Standard; ST056310; (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-13-keto-2,4a,6a,6b,9,9,12a-heptamethyl-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid; AKOS015960428; 471G534; NCGC00258353-01; DB13089; Tox21_110804; CBW; DSSTox_GSID_20669; D0F6IV; MolPort-002-507-130; A827163; (3beta,5beta,14beta)-3-Hydroxy-11-Oxoolean-12-En-29-Oic Acid; 18beta-Glycyrrhetinic acid, 97%; CHEBI:30853; AC-8906; AN-14462; API0002854; BRN 2229654; Glyciram; 18beta-Glycyrrhetinic acid; MCULE-4676598997; 3beta-Hydroxy-11-oxoolean-12-en-30-oic acid; 3-beta-Hydroxy-11-oxoolean-12-en-30-oic acid; BG00824432; Enoxolone [BAN:DCF:INN]; CS-W020624; S00284; Enoxolonum; 299198-00-8 |
分子式: | C30H46O4 |
Smiles: | CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C |
成分: | HBIN002095 |
OB_score: | 22.05261 |
CAS_id: | 471-53-4 |
SymMap_id: | SMIT00577 |
TCMID_id: | 23092 |
TCMSP_id: | MOL004804 |
PubChem_id: | 10114 |
DrugBank_id: | DB13089 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE000312 | Radix Glycyrrhizae Preparata | 炙甘草 | Treatment of deficiency of spleen and stomach, lassitude, palpitation, arrhythmia./Treatment of deficiency of spleen and stomach, lassitude, palpitation, arrhythmia. | |||
TCMBANKHE000541 | 甘草头 | |||||
TCMBANKHE000702 | Radix Glycyrrhizae Praeparata | 炙草 | Treatment of deficiency of spleen and stomach, lassitude, palpitation, arrhythmia./Treatment of deficiency of spleen and stomach, lassitude, palpitation, arrhythmia. | |||
TCMBANKHE001384 | Radix Glycyrrhizae uralensis | 甘草稍 | ||||
TCMBANKHE003349 | 甘草节 | |||||
TCMBANKHE003728 | Radix Glycyrrhizae | 甘草 | To reinforce the function of the spleen and replenish qi, to remove heat and counteract toxicity, to dispel phlegm and relieve cough, to alleviate spasmodic pain, and to moderate drug actions./1. Its decoction can inhibit intestinal smooth muscles of rabbins in vitro, but glycyrrhizin and glycyrrhetinic acid have no this effect.2. Possessing an adrenocorticomimetic effect.3. Its extract and glycyrrhizin exerts a detoxifying effect.4. Antitussive and antiasthmatic. 5. Glycyrrhizin has anti-inflammatory effect similar to hydrocortisone. | |||
TCMBANKHE007721 | Exocarpium Benincasae | 冬瓜皮 | 1. To promote diuresis to relieve edema. 2. To clear summer-heat./Edema, inhibited urination [=dysuria], diarrhea, swelling of sores. | |||
TCMBANKHE008131 | Herba Abri | 鸡骨草 | To remove toxic heat, and to relieve the depressed liver and alleviate pain./Icterohepatitis, stomachache, wind-damp bone pain, stasis pain from knocks and falls, mammary welling abscess. |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000009 | GJA1 | AVSD3; CMDR; CX43; EKVP; EKVP3; GJAL; HLHS1; HSS; ODDD; PPKCA | gap junction protein alpha 1 |
TCMBANKGE000139 | POR | CPR; CYPOR; P450R | cytochrome p450 oxidoreductase |
TCMBANKGE000168 | NR3C1 | GCCR; GCR; GCRST; GR; GRL | nuclear receptor subfamily 3 group C member 1 |
TCMBANKGE000199 | ICAM1 | BB2; CD54; P3.58 | intercellular adhesion molecule 1 |
TCMBANKGE000205 | NOS2 | HEP-NOS; INOS; NOS; NOS2A | nitric oxide synthase 2 |
TCMBANKGE000264 | ABCB1 | ABC20; CD243; CLCS; GP170; MDR1; P-GP; PGY1 | ATP binding cassette subfamily B member 1 |
TCMBANKGE000276 | NOS1 | IHPS1; N-NOS; NC-NOS; NOS; bNOS; nNOS | nitric oxide synthase 1 |
TCMBANKGE000328 | PTPN11 | BPTP3; CFC; JMML; METCDS; NS1; PTP-1D; PTP2C; SH-PTP2; SH-PTP3; SHP2 | protein tyrosine phosphatase non-receptor type 11 |
TCMBANKGE000533 | SLCO1B1 | HBLRR; LST-1; LST1; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6 | solute carrier organic anion transporter family member 1B1 |
TCMBANKGE000639 | HRAS | C-BAS/HAS; C-H-RAS; C-HA-RAS1; CTLO; H-RASIDX; HAMSV; HRAS1; RASH1; p21ras | HRas proto-oncogene, GTPase |
TCMBANKGE000646 | DECR1 | DECR; NADPH; SDR18C1 | 2,4-dienoyl-CoA reductase 1 |
TCMBANKGE001107 | NOS3 | ECNOS; eNOS | nitric oxide synthase 3 |
TCMBANKGE001123 | CTNNB1 | CTNNB; EVR7; MRD19; NEDSDV; armadillo | catenin beta 1 |
TCMBANKGE001171 | SRC | ASV; SRC1; THC6; c-SRC; p60-Src | SRC proto-oncogene, non-receptor tyrosine kinase |
TCMBANKGE001477 | RDH8 | PRRDH; SDR28C2 | retinol dehydrogenase 8 |
TCMBANKGE001528 | DHRS7B | CGI-93; SDR32C1 | dehydrogenase/reductase 7B |
TCMBANKGE001581 | AKR1C4 | 3-alpha-HSD; C11; CDR; CHDR; DD-4; DD4; HAKRA | aldo-keto reductase family 1 member C4 |
TCMBANKGE001692 | RDH12 | LCA13; RP53; SDR7C2 | retinol dehydrogenase 12 |
TCMBANKGE002099 | DHRS7C | SDR32C2 | dehydrogenase/reductase 7C |
TCMBANKGE002369 | RDH5 | 9cRDH; HSD17B9; RDH1; SDR9C5 | retinol dehydrogenase 5 |
TCMBANKGE002388 | NR3C2 | MCR; MLR; MR; NR3C2VIT | nuclear receptor subfamily 3 group C member 2 |
TCMBANKGE002475 | SDR9C7 | ARCI13; RDHS; SDR-O; SDRO | short chain dehydrogenase/reductase family 9C member 7 |
TCMBANKGE002555 | HSD11B1 | 11-DH; 11-beta-HSD1; CORTRD2; HDL; HSD11; HSD11B; HSD11L; SDR26C1 | hydroxysteroid 11-beta dehydrogenase 1 |
TCMBANKGE002793 | JUP | CTNNG; DP3; DPIII; PDGB; PKGB | junction plakoglobin |
TCMBANKGE003092 | HSD11B1L | 11-DH3; 11-beta-HSD3; HSD1L; HSD3; SCDR10; SCDR10B; SDR26C2 | hydroxysteroid 11-beta dehydrogenase 1 like |
TCMBANKGE003649 | RDH14 | PAN2; SDR7C4 | retinol dehydrogenase 14 |
TCMBANKGE004266 | AR | AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM | androgen receptor |
TCMBANKGE004938 | BDH1 | BDH; SDR9C1 | 3-hydroxybutyrate dehydrogenase 1 |
TCMBANKGE005304 | RDH10 | SDR16C4 | retinol dehydrogenase 10 |
TCMBANKGE005507 | HPGD | 15-PGDH; PGDH; PGDH1; PHOAR1; SDR36C1 | 15-hydroxyprostaglandin dehydrogenase |
TCMBANKGE005699 | RDH16 | RODH-4; SDR9C8; hRDH-E | retinol dehydrogenase 16 |
TCMBANKGE005781 | CBR1 | CBR; SDR21C1; hCBR1 | carbonyl reductase 1 |
TCMBANKGE005811 | HSD17B2 | EDH17B2; HSD17; SDR9C2 | hydroxysteroid 17-beta dehydrogenase 2 |
TCMBANKGE006373 | TYW1 | RSAFD1; TYW1A; YPL207W | tRNA-yW synthesizing protein 1 homolog |
TCMBANKGE006375 | SLCO1B3 | HBLRR; LST-2; LST-3TM13; LST3; OATP-8; OATP1B3; OATP8; SLC21A8 | solute carrier organic anion transporter family member 1B3 |
TCMBANKGE006724 | REN | HNFJ2 | renin |
TCMBANKGE006866 | HSD11B2 | AME; AME1; HSD11K; HSD2; SDR9C3 | hydroxysteroid 11-beta dehydrogenase 2 |
TCMBANKGE006933 | DHRS4L2 | SDR25C3 | dehydrogenase/reductase 4 like 2 |
TCMBANKGE007026 | CBR4 | SDR45C1 | carbonyl reductase 4 |
TCMBANKGE008022 | AKR1C3 | DD3; DDX; HA1753; HAKRB; HAKRe; HSD17B5; PGFS; hluPGFS | aldo-keto reductase family 1 member C3 |
TCMBANKGE008077 | AKR1C2 | AKR1C-pseudo; BABP; DD; DD-2; DD/BABP; DD2; DDH2; HAKRD; HBAB; MCDR2; SRXY8; TDD | aldo-keto reductase family 1 member C2 |
TCMBANKGE008362 | PTGR2 | HEL-S-298; PGR2; ZADH1 | prostaglandin reductase 2 |
TCMBANKGE008641 | HSD17B13 | HMFN0376; NIIL497; SCDR9; SDR16C3 | hydroxysteroid 17-beta dehydrogenase 13 |
TCMBANKGE008796 | HSD17B6 | HSE; RODH; SDR9C6 | hydroxysteroid 17-beta dehydrogenase 6 |
TCMBANKGE009006 | C2orf81 | hCG40743 | chromosome 2 open reading frame 81 |
TCMBANKGE009091 | SDR16C5 | EPHD-2; RDH#2; RDH-E2; RDHE2; retSDR2 | short chain dehydrogenase/reductase family 16C member 5 |
TCMBANKGE009446 | DHRS12 | SDR40C1 | dehydrogenase/reductase 12 |
TCMBANKGE009863 | MTRR | MSR; cblE | 5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
TCMBANKGE010106 | HSD17B11 | 17-BETA-HSD11; 17-BETA-HSDXI; 17BHSD11; DHRS8; PAN1B; RETSDR2; SDR16C2 | hydroxysteroid 17-beta dehydrogenase 11 |
TCMBANKGE010124 | DHRS1 | SDR19C1 | dehydrogenase/reductase 1 |
TCMBANKGE010905 | ANPEP | APN; CD13; GP150; LAP1; P150; PEPN | alanyl aminopeptidase, membrane |
TCMBANKGE011011 | DHRSX | CXorf11; DHRS5X; DHRS5Y; DHRSXY; DHRSY; SDR46C1; SDR7C6 | dehydrogenase/reductase X-linked |
TCMBANKGE011293 | RDH11 | ARSDR1; CGI82; HCBP12; MDT1; PSDR1; RALR1; RDJCSS; SCALD; SDR7C1 | retinol dehydrogenase 11 |
TCMBANKGE011300 | DHRS13 | SDR7C5 | dehydrogenase/reductase 13 |
TCMBANKGE011356 | NDOR1 | CIAE1; NR1; bA350O14.9 | NADPH dependent diflavin oxidoreductase 1 |
TCMBANKGE011682 | HSD17B1 | 17-beta-HSD; 20-alpha-HSD; E2DH; EDH17B2; EDHB17; HSD17; SDR28C1 | hydroxysteroid 17-beta dehydrogenase 1 |
TCMBANKGE011927 | CBR3 | HEL-S-25; SDR21C2; hCBR3 | carbonyl reductase 3 |
TCMBANKGE012486 | BDH2 | DHRS6; EFA6R; PRO20933; SDR15C1; UCPA-OR; UNQ6308 | 3-hydroxybutyrate dehydrogenase 2 |
TCMBANKGE012495 | PECR | DCRRP; HPDHASE; HSA250303; PVIARL; SDR29C1; TERP | peroxisomal trans-2-enoyl-CoA reductase |
TCMBANKGE012776 | DECR2 | PDCR; SDR17C1 | 2,4-dienoyl-CoA reductase 2 |
TCMBANKGE012786 | RDH13 | SDR7C3 | retinol dehydrogenase 13 |
TCMBANKGE012862 | DHRS4 | CR; NRDR; PHCR; PSCD; SCAD-SRL; SDR-SRL; SDR25C1; SDR25C2 | dehydrogenase/reductase 4 |
TCMBANKGE013060 | HSD17B8 | D6S2245E; FABG; FABGL; H2-KE6; HKE6; KE6; RING2; SDR30C1; dJ1033B10.9 | hydroxysteroid 17-beta dehydrogenase 8 |
TCMBANKGE013304 | HSDL2 | C9orf99; SDR13C1 | hydroxysteroid dehydrogenase like 2 |
TCMBANKGE013338 | CTNNA1 | CAP102; MDPT2 | catenin alpha 1 |
TCMBANKGE014135 | HSD17B14 | DHRS10; SDR47C1; retSDR3 | hydroxysteroid 17-beta dehydrogenase 14 |
TCMBANKGE014269 | AKR1C1 | 2-ALPHA-HSD; 20-ALPHA-HSD; C9; DD1; DD1/DD2; DDH; DDH1; H-37; HAKRC; HBAB; MBAB | aldo-keto reductase family 1 member C1 |
TCMBANKGE014938 | DHRS2 | HEP27; SDR25C1 | dehydrogenase/reductase 2 |